Evidence map›Paper›PMID 41372257›Full record

ArticleScientific reports2025

Ophtimus-V2-Tx: a compact domain-specific LLM for ophthalmic diagnosis and treatment planning.

Minwook Kwon, Kuk Jin Jang, Seung Ju Baek, Yong Seop Han, Hyonyoung Choi, Insup Lee, Jin Hyun Kim

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Minwook KwonDepartment of AI Convergence Engineering, Gyeongsang National University, Jinju, South Korea.
Kuk Jin JangDepartment of Computer Engineering, Hongik University, Seoul, South Korea.
Seung Ju BaekDepartment of AI Convergence Engineering, Gyeongsang National University, Jinju, South Korea.
Yong Seop HanDepartment of Ophthalmology, Changwon Hanmaeum Hospital, Changwon, South Korea.
Hyonyoung ChoiPRECISE Center and Department of Computer and Information Science, University of Pennsylvania, Philadelphia, PA, USA.
Insup LeePRECISE Center and Department of Computer and Information Science, University of Pennsylvania, Philadelphia, PA, USA.
Jin Hyun KimDepartment of AI Convergence Engineering, Gyeongsang National University, Jinju, South Korea. jin.kim@gnu.ac.kr.

Funding

SCH: Robust and Equitable Clinical Decision Support in Glaucoma Detection and Progression PredictionR01EY037101 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Lama A Al-Aswad, Osbert Bastani · 2024 to 2026
$851k
National Research Foundation of Korea NRF-2023R1A2C1006639NEI NIH HHS R01 EY037101
6 · The paper itself

Abstract

Large language models (LLMs) show promise for clinical decision support but often struggle with case-specific reasoning. We present Ophtimus-V2-Tx, an 8-billion-parameter ophthalmology-specialized LLM fine-tuned on more than 10,000 case reports. Evaluation is conducted on a pre-collected dataset. Alongside text metrics (ROUGE-L, BLEU, METEOR) and a semantic similarity score, we use CliBench to map outputs to standardized codes (ICD-10-CM, ATC, ICD-10-PCS) and compute hierarchical F1 (L1-L4 and Full), with code mapping used strictly as an evaluation tool. Ophtimus-V2-Tx is competitive with a state-of-the-art general model and stronger in several settings. It improves text metrics (ROUGE-L 0.40 vs. 0.18; BLEU 0.26 vs. 0.05; METEOR 0.45 vs. 0.29) with comparable semantic similarity. On CliBench, it attains a higher full-code score for secondary diagnosis and ties or leads at selected granular levels for primary diagnosis, while medication and procedure results are close with overlapping confidence intervals. Relative to other ophthalmology-tuned baselines, it shows consistently higher text-generation scores. These findings indicate that a compact, domain-adapted model can approach-or in targeted settings, exceed-large general LLMs on clinically grounded outputs while remaining feasible for on-premise use. We also describe an auditable evaluation pipeline (frozen coding agent, identical prompts, hierarchical metrics) to support reproducibility and future benchmarking.

Indexed as

Eye DiseasesOphthalmologyClinical Decision-MakingHumans

Identifiers

PMID41372257
PMCPMC12695966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.